Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review

Detalhes bibliográficos
Autor(a) principal: Ribas e Ribas,Aícha Daniela
Data de Publicação: 2016
Outros Autores: Spolti,Pierri, Del Ponte,Emerson Medeiros, Donato,Katarzyna Zawada, Schrekker,Henri, Fuentefria,Alexandre Meneghello
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Microbiology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793
Resumo: Abstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments.
id SBM-1_0672355649688beb57294a916a32e7a8
oai_identifier_str oai:scielo:S1517-83822016000400793
network_acronym_str SBM-1
network_name_str Brazilian Journal of Microbiology
repository_id_str
spelling Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini reviewCross-resistanceEmerging fungal pathogensFungicide sensitivityAgricultureMedicineAbstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments.Sociedade Brasileira de Microbiologia2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793Brazilian Journal of Microbiology v.47 n.4 2016reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1016/j.bjm.2016.06.006info:eu-repo/semantics/openAccessRibas e Ribas,Aícha DanielaSpolti,PierriDel Ponte,Emerson MedeirosDonato,Katarzyna ZawadaSchrekker,HenriFuentefria,Alexandre Meneghelloeng2016-11-21T00:00:00Zoai:scielo:S1517-83822016000400793Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2016-11-21T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false
dc.title.none.fl_str_mv Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
title Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
spellingShingle Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
Ribas e Ribas,Aícha Daniela
Cross-resistance
Emerging fungal pathogens
Fungicide sensitivity
Agriculture
Medicine
title_short Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
title_full Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
title_fullStr Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
title_full_unstemmed Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
title_sort Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
author Ribas e Ribas,Aícha Daniela
author_facet Ribas e Ribas,Aícha Daniela
Spolti,Pierri
Del Ponte,Emerson Medeiros
Donato,Katarzyna Zawada
Schrekker,Henri
Fuentefria,Alexandre Meneghello
author_role author
author2 Spolti,Pierri
Del Ponte,Emerson Medeiros
Donato,Katarzyna Zawada
Schrekker,Henri
Fuentefria,Alexandre Meneghello
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ribas e Ribas,Aícha Daniela
Spolti,Pierri
Del Ponte,Emerson Medeiros
Donato,Katarzyna Zawada
Schrekker,Henri
Fuentefria,Alexandre Meneghello
dc.subject.por.fl_str_mv Cross-resistance
Emerging fungal pathogens
Fungicide sensitivity
Agriculture
Medicine
topic Cross-resistance
Emerging fungal pathogens
Fungicide sensitivity
Agriculture
Medicine
description Abstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjm.2016.06.006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
dc.source.none.fl_str_mv Brazilian Journal of Microbiology v.47 n.4 2016
reponame:Brazilian Journal of Microbiology
instname:Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
instname_str Sociedade Brasileira de Microbiologia (SBM)
instacron_str SBM
institution SBM
reponame_str Brazilian Journal of Microbiology
collection Brazilian Journal of Microbiology
repository.name.fl_str_mv Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)
repository.mail.fl_str_mv bjm@sbmicrobiologia.org.br||mbmartin@usp.br
_version_ 1752122208727072768